【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY INDICATION
• Segmentation by indication
• Comparison by indication
• MD drugs
• DED drugs
• Others
• Market opportunity by indication
PART 08: MARKET SEGMENTATION BY DRUG CLASS
• Segmentation by drug class
• Anti-VEGF agents
• Corticosteroids
• Others
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Retinal drugs market in Americas
• Retinal drugs market in EMEA
• Retinal drugs market in APAC
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Development of innovative therapies
• Rise in demand for sustained-release ocular formulations
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS0
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• Bayer
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Valeant Pharmaceuticals
PART 16: APPENDIX
• List of abbreviations
• Exhibit 01: Parent market
• Exhibit 02: Global ophthalmic drugs market segmentation
• Exhibit 03: Market characteristics
• Exhibit 04: Market segments
• Exhibit 05: Market definition – Inclusions and exclusions checklist
• Exhibit 06: Market size 2017
• Exhibit 07: Validation techniques employed for market sizing 2017
• Exhibit 08: Global retinal drugs market – Market size and forecast 2017-2022 ($ mn)
• Exhibit 09: Global retinal drugs market – Year-over-year growth 2018-2022 (%)
• Exhibit 10: Five forces analysis 2017
• Exhibit 11: Five forces analysis 2022
• Exhibit 12: Bargaining power of buyers
• Exhibit 13: Bargaining power of suppliers
• Exhibit 14: Threat of new entrants
• Exhibit 15: Threat of substitutes
• Exhibit 16: Threat of rivalry
• Exhibit 17: Market condition – Five forces 2017
• Exhibit 18: Global retinal drugs market – Market share by indication 2017-2022 (%)
• Exhibit 19: Comparison by indication
• Exhibit 20: Global MD drugs market – Market size and forecast 2017-2022 ($ mn)
• Exhibit 21: Global MD drugs market – Year-over-year growth 2018-2022 (%)
• Exhibit 22: Global DED drugs market – Market size and forecast 2017-2022 ($ mn)
• Exhibit 23: Global DED drugs market – Year-over-year growth 2018-2022 (%)
• Exhibit 24: Global other retinal diseases drugs market – Market size and forecast 2017-2022 ($ mn)
• Exhibit 25: Global other retinal diseases drugs market – Year-over-year growth 2018-2022 (%)
• Exhibit 26: Market opportunity by indication
• Exhibit 27: Global retinal drugs market share by drug class 2017 (%)
• Exhibit 28: Major anti-VEGF agents approved in the market
• Exhibit 29: Major corticosteroids approved in the market
• Exhibit 30: Customer landscape
• Exhibit 31: Global retinal drugs market – Market share by geography 2017-2022 (%)
• Exhibit 32: Regional comparison
• Exhibit 33: Retinal drugs market in Americas – Market size and forecast 2017-2022 ($ mn)
• Exhibit 34: Retinal drugs market in Americas – Year-over-year growth 2018-2022 (%)
• Exhibit 35: Top 3 countries in Americas
• Exhibit 36: Retinal drugs market in EMEA – Market size and forecast 2017-2022 ($ mn)
• Exhibit 37: Retinal drugs market in EMEA – Year-over-year growth 2018-2022 (%)
• Exhibit 38: Top 3 countries in EMEA
• Exhibit 39: Retinal drugs market in APAC – Market size and forecast 2017-2022 ($ mn)
• Exhibit 40: Retinal drugs market in APAC – Year-over-year growth 2018-2022 (%)
• Exhibit 41: Top 3 countries in APAC
• Exhibit 42: Market opportunity
• Exhibit 43: Vendor landscape
• Exhibit 44: Landscape disruption
• Exhibit 45: Vendors covered
• Exhibit 46: Vendor classification
• Exhibit 47: Market positioning of vendors
• Exhibit 48: ALLERGAN – Overview
• Exhibit 49: ALLERGAN – Business segments
• Exhibit 50: ALLERGAN – Organizational developments
• Exhibit 51: ALLERGAN – Geographic focus
• Exhibit 52: ALLERGAN – Segment focus
• Exhibit 53: ALLERGAN – Key offering
• Exhibit 54: ALLERGAN – Key customers
• Exhibit 55: Bayer – Overview
• Exhibit 56: Bayer – Business segments
• Exhibit 57: Bayer – Organizational developments
• Exhibit 58: Bayer – Geographic focus
• Exhibit 59: Bayer – Segment focus
• Exhibit 60: Bayer – Key offerings
• Exhibit 61: Bayer – Key customers
• Exhibit 62: F. Hoffmann-La Roche – Overview
• Exhibit 63: F. Hoffmann-La Roche – Business segments
• Exhibit 64: F. Hoffmann-La Roche – Organizational developments
• Exhibit 65: F. Hoffmann-La Roche – Geographic focus
• Exhibit 66: F. Hoffmann-La Roche – Segment focus
• Exhibit 67: F. Hoffmann-La Roche – Key offerings
• Exhibit 68: F. Hoffmann-La Roche – Key customers
• Exhibit 69: Novartis – Overview
• Exhibit 70: Novartis – Business segments
• Exhibit 71: Novartis – Organizational developments
• Exhibit 72: Novartis – Geographic focus
• Exhibit 73: Novartis – Segment focus
• Exhibit 74: Novartis – Key offerings
• Exhibit 75: Novartis – Key customers
• Exhibit 76: Regeneron Pharmaceuticals – Overview
• Exhibit 77: Regeneron Pharmaceuticals – Business segments
• Exhibit 78: Regeneron Pharmaceuticals – Organizational developments
• Exhibit 79: Regeneron Pharmaceuticals – Geographic focus
• Exhibit 80: Regeneron Pharmaceuticals – Segment focus
• Exhibit 81: Regeneron Pharmaceuticals – Key offerings
• Exhibit 82: Regeneron Pharmaceuticals – Key customers
• Exhibit 83: Valeant Pharmaceuticals – Overview
• Exhibit 84: Valeant Pharmaceuticals – Business segments
• Exhibit 85: Valeant Pharmaceuticals – Organizational developments
• Exhibit 86: Valeant Pharmaceuticals – Geographic focus
• Exhibit 87: Valeant Pharmaceuticals – Segment focus
• Exhibit 88: Valeant Pharmaceuticals – Key offerings
• Exhibit 89: Valeant Pharmaceuticals – Key customers
【レポート販売概要】
■ タイトル：網膜用治療薬の世界市場2018-2022■ 英文：Global Retinal Drugs Market 2018-2022
■ 発行日：2018年4月16日
■ 調査会社：Technavio
■ 商品コード：IRTNTR22469
■ 調査対象地域：グローバル
- Goodrich Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Goodrich Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Goodrich Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is a …
- 東南アジアの生命保険市場2016-2020About the Life Insurance Market in Southeast Asia The 2007 financial crisis shattered many economies across the globe, and triggered a negative shift in customer demand, especially in the life insurance sector. The drop in income not only reduced demand for life insurance policies and products but also curtailed the market penetration of the industry. In the current market scenario, there are many …
- エコ繊維の世界市場：有機繊維、リサイクル繊維、再生繊維The global eco fibers market size, in terms of value, is projected to reach USD 74.65 Billion by 2020, and is projected to record a CAGR of 11.46% between 2015 and 2020. In terms of volume, the global eco fibers market is projected to reach 21,984.9 kilotons by 2020, at a CAGR of 10.38% during the forecast period. The increasing awareness among the common population about environment conservation …
- グローバル電子請求（e-Invoicing）市場動向（2014-2018）About e-invoicing E-invoicing is the exchange of bills and related invoice documents between enterprises and their clients in an integrated electronic format, usually using the internet. Also known as e-billing, e-invoicing is a part of electronic data interchange transactions that include data from the enterprise in a format that can be integrated into the client's financial system without the in …
- 口腔癌：グローバル臨床試験レビュー（2014年上半期）Oral Cavity (Mouth) Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Oral Cavity (Mouth) Cancer Global Clinical Trials Review, H1, 2014" provides data on the Oral Cavity (Mouth) Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oral Cavity (Mouth) Cancer. It includes an overview of the t …
- 世界の腎臓結石管理装置市場動向（2014-2018）About Kidney Stones Management Devices Kidney stones are mineral and acid salts such as calcium crystals that are formed in the kidneys. The formation of stones in the kidneys is known as urolithiasis, which is one of the most common urological disorders worldwide. It causes obstruction to the drainage of urine from the kidneys and often causes severe pain. Kidney stone management devices help to …
- 機械翻訳の世界市場2015-2019About Machine Translation Machine translation (MT) is the translation of words by a computer from one language to another. It is one of the major sub-fields of computational linguistics, and deals with statistical or rule-based modeling of natural language. It enables speedy translation of documents and content. It is a cost-effective method employed by several companies to create multilingual con …
- Bacteremia：グローバル臨床試験レビューH2, 2013Bacteremia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Bacteremia Global Clinical Trials Review, H2, 2013" provides data on the Bacteremia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacteremia. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- 世界の小売産業におけるワークフォース管理（WFM）ソフトウェア市場About Workforce Management Software Traditionally, workforce management was handled with the help of spreadsheets and time recording, which are time-consuming, can lead to non-productive idle times and poor customer services, and incur high operational costs. WFM software helps businesses to manage workforce scheduling, increase operational performance, and identify and solve workforce-related iss …
- AGL Energy Limited：発電所及びSWOT分析2013AGL Energy Limited - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and …
- 防弾チョッキの世界市場2016-2020About Bullet Proof Vest A bulletproof vest, also known as a bullet-resistant vest or ballistic vest is a type of personal protective equipment. It is used by the military, law enforcement personals, and many times by civilians as a protective cover against bullets and shrapnel from explosions. Soft bulletproof vests weigh less and provide protection against small-caliber handguns. Hard bulletproof …
- 世界のコンフォーマルコーティング装置市場2015The Global Conformal Coatings Equipmnet Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Conformal Coatings Equipmnet industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Conformal Coatings Equipmnet market analysis is provided for the international m …
- 世界の糖尿病性足部潰瘍治療薬市場OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis And Forecasts To 2017 - Event-Driven Update Summary Diabetic foot ulcers (DFUs) are a common complication of diabetes, and with the increasing prevalence of diabetes across all markets, the number of patients suffering from DFUs is also expected to rise. Despite the availability of various treatment modalities, there are currently fe …
- ポリエーテルアミンの世界市場予測（～2022年）：モノアミン、ジアミン、トリアミンThe global polyetheramine market is projected to reach USD 1,074.0 Million by 2022, at a CAGR of 9.3% from 2017 to 2022. The growing use of polyetheramine in different applications such as epoxy coatings, composites, polyurea, and adhesives & sealants for construction and wind energy industry is driving the market for polyetheramine. The use of polyetheramine-based composites in the wind energy in …
- 携帯型通信装置の世界市場2016-2020About Man-portable Communication Systems A man-portable communication system is an easily movable or handheld communication device used for on-site and tactical defense communications. These compact systems are capable of overcoming background noises caused by vehicles, military tanks, sirens, vessels, and boisterous crowds, and ensure that each message is clearly heard and understood. Man-portabl …
